Sickle Cell Research for Treatment and Cure

Sickle Cell Research for Treatment and Cure commemorates the 30th anniversary of the National Sickle Cell Anemia Control Act (P. L. 92-294). The law provided for establishment of voluntary sickle cell anemia screening and counseling programs; information and education programs for health professionals and the public; and research and research training in the diagnosis, treatment, and control of sickle cell anemia. Since then, the NHLBI has committed over $923 million for research programs to improve the lives of persons with sickle cell disease. The booklet describes a range of NHLBI activities, including the

Penicillin Prophylaxis in Sickle Cell Disease Studies.

Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Stroke Prevention Trials in Sickle Cell Anemia.

It also mentions examples of how basic science advances achieved prior to the 1970s enabled progress against sickle cell disease and describes ongoing studies to develop a cure.

Information about Document Format

This document is available for viewing, printing, and downloading (saving) in Adobe Acrobat's portable document format (PDF). You need the Acrobat Reader installed on your computer and configured to work in your browser to access the PDF version. When viewed or printed in the Acrobat Reader, the document appears as it does in the printed copy version.

If you do not have the Acrobat Reader, you may download a free copy from Adobe

Attention blind and visually impaired viewers:
Access.Adobe.Com is a tool that allows blind and visually impaired users to read any document in Adobe PDF. The tool converts PDF documents into simple HTML or ASCII text that can then be read by a number of common screen reading programs that synthesize the HTML as audible speech.

Skip to content past banner and navigation links U.S. Department of Health & Human Services National Institutes of Health Contact Us Get Email Alerts Font Size Accessible Search Form Advanced Search Search the NHLBI, use the drop down list to select: the entire site, the Health Topics section only, or the News and Resources section. NHLBI Entire Site NHLBI Entire Site1 Health Topics2 News & Resources3 Intramural Research4
Home » About NHLBI » NHLBI Overview and Planning Documents » Sickle Cell Research for Treatment and Cure
About NHLBI NHLBI Organization Overview & Planning Documents Advisory and Peer Review Committees Budget and Legislative Information	Sickle Cell Research for Treatment and Cure Sickle Cell Research for Treatment and Cure commemorates the 30th anniversary of the National Sickle Cell Anemia Control Act (P. L. 92-294). The law provided for establishment of voluntary sickle cell anemia screening and counseling programs; information and education programs for health professionals and the public; and research and research training in the diagnosis, treatment, and control of sickle cell anemia. Since then, the NHLBI has committed over $923 million for research programs to improve the lives of persons with sickle cell disease. The booklet describes a range of NHLBI activities, including the Penicillin Prophylaxis in Sickle Cell Disease Studies. Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Stroke Prevention Trials in Sickle Cell Anemia. It also mentions examples of how basic science advances achieved prior to the 1970s enabled progress against sickle cell disease and describes ongoing studies to develop a cure. Information about Document Format This document is available for viewing, printing, and downloading (saving) in Adobe Acrobat's portable document format (PDF). You need the Acrobat Reader installed on your computer and configured to work in your browser to access the PDF version. When viewed or printed in the Acrobat Reader, the document appears as it does in the printed copy version. If you do not have the Acrobat Reader, you may download a free copy from Adobe Attention blind and visually impaired viewers: Access.Adobe.Com is a tool that allows blind and visually impaired users to read any document in Adobe PDF. The tool converts PDF documents into simple HTML or ASCII text that can then be read by a number of common screen reading programs that synthesize the HTML as audible speech. [PDF document, 432 K]